Small victories add up to paradigm shifts for hard-to-treat tumorsDecember 17, 2014GastroenterologyGynecologic CancerMelanoma
Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutationsJuly 22, 2014Melanoma
Current options and future directions in the systemic treatment of metastatic melanomaFebruary 4, 2014MelanomaPatient & Survivor Care
Key issues in the management of gastrointestinal immune-related adverse events associated with ipilimumab administrationDecember 12, 2013MelanomaPatient & Survivor Care
A severe case of cutaneous squamous cell carcinoma keratoacanthoma type in a 55-year-old manMay 29, 2013Melanoma
